Table 2.
A working definition of cirrhotic cardiomyopathy |
A cardiac dysfunction in patients with cirrhosis characterised by impaired contractile responsiveness to stress and/or altered diastolic relaxation with electrophysiological abnormalities in the absence of other known cardiac disease |
Diagnostic criteria |
Systolic dysfunction |
Blunted increase in cardiac output on exercise, volume challenge or pharmacological stimuli |
Resting LVEF < 55% |
Diastolic dysfunction |
E/A ratio < 1 (age-corrected) |
Prolonged deceleration time (> 200 ms) |
Prolonged isovolumetric relaxation time (> 80 ms) |
Supportive criteria |
Electrophysiological abnormalities |
Abnormal chronotropic response |
Electromechanical uncoupling |
Prolonged QTc interval |
Enlarged left atrium |
Increased myocardial mass |
Increased BNP (brain natriuretic peptide) and pro-BNP |
Increased troponinI |
BNP: B-type natriuretic peptide; LVEF: Left ventricular ejection fraction.